Phosphate Binders in CKD: ‟New Kids on the Block”

Ùghdaran

  • Muhammad Umair Afzal
  • Shafeeq Cheema Jinah Hospital, Lahore

##semicolon##

https://doi.org/10.53778/pjkd31089

##semicolon##

hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxide

Geàrr-chunntas

Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.

PJKD

##submission.downloads##

Foillsichte

2021-02-05

Iris

Lbh. 3 Àir. 10 (2019): Pakistan Journal of Kidney Diseases

Earrann

Review Article

##submission.license##

##submission.copyrightStatement##

##submission.license.cc.by-nc4.footer##

##submission.howToCite##

Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089